Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.

Founded in 1989, OrbiMed is a New York-based healthcare-dedicated investment firm managing approximately $5 billion in assets. It invests across the spectrum of healthcare companies, from private start-ups to large multinational corporations, focusing on biopharmaceuticals, life sciences, digital health, medical devices, and diagnostics sectors globally.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a technology-focused capital provider based in Philadelphia, founded in 1982 to advance the region's technology community. The organization funds and supports technology companies across Pennsylvania, especially in information technology, health, and physical sciences, investing substantial capital in early-stage and established ventures. It has invested over 170 million dollars in more than 1,750 regional technology companies and has launched university-industry partnerships to translate scientific discoveries into commercial products, while seeding regional initiatives that strengthen the entrepreneurial ecosystem and create jobs.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.

Established in 1999, Innovation Works is a prominent investor in Southwestern Pennsylvania's technology sector. It provides capital and resources to early-stage companies with high growth potential and significant regional impact, particularly focusing on robotics, AI, medical devices, retail technologies, and enterprise software.

Eli Lilly and Company is a global pharmaceutical leader engaged in the discovery, development, manufacture, and sale of medicines. It operates facilities in the United States, Puerto Rico, and many other countries, with products sold in about 135 countries. The company focuses on therapies in neuroscience, cardiometabolic, cancer, and immunology, and also conducts research in animal health and animal agriculture. Lilly supports patient outcomes and education through a philanthropic foundation that funds programs in underserved communities, including STEM education in Indianapolis.

HealthTech Capital is an angel investment group based in Los Altos Hills, California, founded in 2010. The group focuses on funding and mentoring emerging health-tech startups that operate at the intersection of healthcare, technology, and mobility. By fostering collaboration among leading clinical providers, venture firms, and other strategic industry players, HealthTech Capital aims to create a robust ecosystem that supports innovative solutions in the health sector.

Founded in 2000, Gilde Healthcare Partners is a specialized investment firm focused on the healthcare sector. It manages multiple funds totaling over €800 million and invests in digital health, diagnostics, medical devices, therapeutics, and healthcare services across Europe and North America. The firm prefers to lead investments ranging from €1 million to €35 million, taking minority or majority stakes between 5% and 40%. It seeks to add value through active board participation and exits via IPOs, strategic sales, or private placements.

Founded in Boston in 2004, RA Capital is an investment firm specializing in life sciences and drug development. Its team, with backgrounds in biology, chemistry, medicine, and industry experience, invests in early-stage companies with promising technologies and products across healthcare and life science sectors.

U.S. Venture Partners is a Menlo Park-based venture capital firm established in 1981 that concentrates on early-stage and growth investments in technology and healthcare. The firm backs business-to-business software, IT security, consumer internet, mobile, e-commerce, and IT-enabled healthcare services, as well as digital health, cloud technology, and life sciences including oncology. Its focus spans enterprise software, cybersecurity, healthcare IT, SaaS, manufacturing, and related sectors on the West Coast. The team comprises former entrepreneurs, technologists, executives, and industry experts who help portfolio companies scale and reach customers.

Legend Capital is a Beijing-based venture capital firm and subsidiary of Legend Holdings. Founded in 2001, it focuses on early-stage and growth investments in technology-driven sectors with operations anchored in China and related markets. The firm backs companies in IT, internet applications and services, outsourcing, IC design and key components, as well as sectors such as telecommunications, media, healthcare, consumer and intelligent manufacturing. It manages multiple funds and actively supports portfolio companies with business development, market positioning and access to Chinese markets to create value. Legend Capital aims to back high-growth ventures and build lasting value in China's venture capital ecosystem.

Founded in 1999, Versant Ventures is a global healthcare investment firm dedicated to supporting exceptional entrepreneurs building innovative companies. With over $2 billion under management and offices across North America and Europe, the firm invests across all stages of healthcare company development, with a focus on novel therapeutics. Versant's team, with deep investment, operating, and scientific expertise, takes a hands-on approach to company building.

Established in 1973, Johnson & Johnson Innovation facilitates early-stage innovation through strategic partnerships. It connects potential collaborators with resources to advance transformative science and technology across pharmaceuticals, medical devices, and consumer healthcare sectors.

Founded in Paris in 1972, Sofinnova Partners is a venture capital firm dedicated to life sciences investments. With over €2 billion under management, the firm actively partners with entrepreneurs from seed to later-stage, focusing on biopharmaceuticals, medical devices, and industrial biotechnology. Sofinnova proactively sources deals, often leading Round A financings, and plays an active role in portfolio companies until exit.

IP Group is a London-based corporate firm that provides financial, strategic, and commercial expertise to clients internationally. Founded in 2001, the company focuses on creating value through the commercialisation of intellectual property derived from research-intensive institutions. It manages the end-to-end process of identifying viable IP, developing or partnering to build value, and establishing commercial arrangements that translate scientific advances into practical products and businesses. IP Group combines industry insight and financial experience to support science- and technology-based ventures, offering capital as well as strategic guidance to help companies grow and accelerate the impact of research. Its work spans clean technology, life sciences, and other deep technology sectors, with a track record of backing and developing ventures that aim to deliver tangible societal and economic outcomes.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

Deerfield Management is a New York-based investment firm established in 1994 that focuses on healthcare. It operates across investment, information, and philanthropy to support the healthcare ecosystem. The firm provides private and public investments and offers long-term, structured capital to both public and private healthcare companies. Its portfolio spans life sciences, medical devices, diagnostics, digital health, and health services. As an investment adviser, it seeks opportunities in healthcare products and services and aims to accelerate innovation by combining capital with industry insight.

Sand Hill Angels, established in 2000, is a prominent angel investor group based in Mountain View, California, comprising over 60 successful Silicon Valley technology professionals. The group is dedicated to supporting and growing startup companies, with a focus on seed-stage technology investments across North America. They typically invest between $300,000 to $500,000 in private companies, with a pre-money valuation of less than $5 million. Sand Hill Angels' investment preferences span various sectors, including clean technology, Internet startups, information sciences, and life sciences, with a particular interest in semiconductors, enterprise software, storage, communications, medical devices, diagnostics, and bioinformatics. The group collaborates openly with venture capital funds, other angel organizations, and the broader Bay Area ecosystem to foster the growth of technology startups.

Sequoia Capital Israel is a venture capital firm that backs startups and growth companies across seed to late-stage rounds, with a focus on Israel. It invests across sectors including fintech, financial services, internet, mobile, technology, and healthcare, spanning banking, payments, advertising, ecommerce, data, security, software, and related enabling tech. Typical commitments range from 100,000 to 1 million in seed, 1 to 10 million in early venture, and 10 to 100 million in growth rounds. The firm is based in Tel Aviv and operates as part of Sequoia Capital's global network.

Novo Holdings is a Danish holding and investment firm managing the assets of the Novo Nordisk Foundation. Established in 1999, it invests globally in life science companies at all stages of development, with a portfolio also including equities, bonds, real estate, and infrastructure.

SV Health Investors is a venture capital and growth equity firm focused on healthcare and life sciences. Headquartered in the United States with offices in Boston, San Francisco and London, the firm supports entrepreneurs who develop breakthrough medicines, devices and related technologies. It manages multiple private healthcare funds and has a 20-year track record in the US and Europe, investing across North America and Western Europe to advance innovative treatments and diagnostics. SV Health Investors aims to transform healthcare by backing early-stage and growth opportunities in biotechnology, medical devices and related sectors.

Arboretum Ventures is a Michigan-based venture capital firm, founded in 2002 and headquartered in Ann Arbor. It focuses on seed-, early-, mid-, and growth-stage investments in the healthcare sector, including services, medical devices, diagnostics, healthcare information technology, therapeutics, life science tools, and technology-enabled health care delivery. The firm makes investments across the United States, with emphasis on the Midwest and Michigan, partnering with companies at various stages to support growth in healthcare. Arboretum Ventures operates as a specialized investor in healthcare, aiming to back companies developing novel tools and technologies that advance patient care.

SFC Capital is a United Kingdom based venture capital firm founded in 2012 that focuses on early-stage investments, including pre-seed and seed rounds, in sectors such as software, technology, e-commerce, consumer products, enterprise solutions, green technology, medical technology, and hospitality. It backs UK startups through an Angel Network and seed funds, providing capital and guidance and offering access to SEIS- and EIS-qualifying investment opportunities. The firm is described as a leading seed investor in the UK.

MassVentures is a venture capital firm based in Waltham, Massachusetts, established in 1978 as a quasi-public corporation by the Massachusetts Legislature. The firm focuses on providing seed and early-stage funding to high-growth startups, facilitating their transition from concept to commercialization. MassVentures invests primarily in sectors such as information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics. With a governance structure that includes an independent Board of Directors and management by experienced venture capitalists, MassVentures leverages the state's entrepreneurial spirit and innovation centers to support the Massachusetts innovation economy. The firm also offers accelerator programs to further assist emerging companies in their growth journey.

Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.

ShangBay Capital is a California-based venture capital firm founded in 2015 and headquartered in Palo Alto. It focuses on early-stage investments in United States healthcare technology sectors, including life sciences, medical devices, biotechnology, and mobile health. The firm seeks to back companies developing innovative medical technologies and digital health solutions, providing capital and strategic support to help accelerate product development, regulatory pathways, and commercial deployment. By concentrating on early-stage opportunities in health tech, ShangBay Capital aims to partner with founders to advance next-generation healthcare capabilities.

Panakes Partners is a Milan-based venture capital firm founded in 2015 that specializes in early-stage investments in life sciences and healthcare across Europe and Israel. It backs ambitious teams developing innovative technologies and products to improve human health, providing capital and strategic guidance to move scientific discoveries toward practical market applications.

Founded in 2000, Hatteras Venture Partners is a venture capital firm based in Durham, North Carolina. It specializes in early-stage investments in life sciences and healthcare companies, with a focus on biopharmaceuticals, medical devices, diagnostics, and healthcare IT. The firm primarily invests in companies located in the Mid Atlantic and Southeastern United States.

IDG Capital is a Beijing-based venture and growth-stage investment firm that backs technology-enabled companies across global markets, with a strong emphasis on China and Asia. It invests across seed, early, later, and growth stages and pursues buyouts, with interests spanning information technology, software, consumer products and services, healthcare, energy, SaaS, mobile, TMT, and advanced manufacturing. The firm leverages a worldwide network of limited partners, including sovereign wealth funds, pension funds, institutional investors, and philanthropic and educational endowments, to support portfolio companies. With deep local market knowledge and extensive relationships with business leaders, IDG Capital combines global perspective with local execution to facilitate inbound and outbound opportunities in China and the broader Asian region.

Right Side Capital Management is a San Francisco-based venture capital firm that focuses on early-stage, pre-seed technology startups in underserved segments of the ecosystem. It invests in a high-volume, capital-efficient portfolio, typically funding rounds of 50,000 to 500,000 and making roughly 75 to 100 investments per year. The firm targets opportunities across the United States and internationally, including Canada, Israel, Australia, New Zealand, and Western Europe, prioritizing companies with scalable products and prudent capital use outside major metro hubs. Since its inception, it has built a broad portfolio across many states. It commits to a fast decision process, often delivering a yes or no within two weeks to help founders establish momentum.

Founded in Toronto in 2007, Lumira Ventures is a venture capital firm focusing on investments in biotechnology, biopharmaceuticals, medical devices, digital health, and consumer health companies. With offices across North America, the firm invests primarily in Canada and the United States, typically allocating between USD 5 million to USD 15 million per investment. Lumira Ventures actively supports its portfolio companies by facilitating access to funding sources, partners, and market opportunities.

Founded in 2010, Verve Ventures is a European venture capital firm headquartered in Switzerland. It operates a digital investment platform for qualified investors, enabling them to build diversified startup portfolios with investments starting at EUR 10,000. With over EUR 130 million invested in over 100 startups and a community of 5,000 registered investors, Verve Ventures focuses on science and technology sectors, sourcing top deals and structuring rounds for its investors.

Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco that backs early-stage and Series A technology companies across sectors such as artificial intelligence, B2B software, consumer technology, fintech, health tech, infrastructure, and semiconductors. The firm emphasizes practical, founder-centered collaboration, often supporting concepts from idea stage through Series A and taking board seats to help portfolio companies scale. It operates globally, including Matrix Partners China, which focuses on long-term relationships with entrepreneurs in China and has a track record of IPOs and strategic exits. The team combines former founders and experienced investors to bring local execution and global perspective. Notable investments span across the technology landscape, reflecting a history of involvement with companies like FedEx, Apple, Oculus, Canva, Zendesk, HubSpot, Postmates, Fivetran, Sila, and GOAT, illustrating the firm’s ability to support companies from early development to scale.

Founded in 1863, Mayo Clinic is a non-profit organization based in Minnesota, United States. It provides comprehensive medical care services across various specialties, conducts extensive research, and offers education in clinical medicine.

Kurma Partners is a Paris-based investment firm founded in 2009 that concentrates on financing innovation in healthcare and biotechnology across Europe. It targets early-stage and development capital for companies in life sciences, biotechnology, digital health, and related fields, and emphasizes collaborations with research institutes and hospitals to advance therapies and medical technologies from concept to clinical development. The firm operates as a specialist investor in Europe, supporting ventures that bridge scientific discovery and patient impact through equity investments and strategic guidance.

Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. With approximately $5.8 billion in assets under management and investments in over 290 public and private companies worldwide, the firm operates from Palo Alto, California, with additional offices in Asia. Its team comprises 50 multidisciplinary professionals, including physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo Capital invests across various healthcare sectors such as biotechnology, pharmaceuticals, medical devices, and healthcare services.

Founded in 2013, Ally Bridge Group is a global healthcare investment firm headquartered in New York. It focuses on private and public equity investments in pioneering life sciences companies and technologies that address major unmet medical needs.

Founded in 2000, General Catalyst is a venture capital firm specializing in early-stage and growth equity investments. It focuses on accelerating ideas, careers, and companies towards success by providing ongoing momentum and mentorship based on deep experience.

Founded in Rome, Italy in 2015, CDP Venture Capital is a venture capital firm dedicated to fostering innovation and economic growth. It invests in early-stage and growth companies across various sectors, with a focus on Italian startups.

Polaris Partners is a venture capital firm based in Boston, Massachusetts, with offices in San Francisco. Founded in 1996, it targets investments in technology and life science companies across the United States and Europe, supporting startups from early formation to profitable growth. The firm's healthcare and biotechnology focus encompasses digital health, consumer-centric care delivery, patient-provider solutions, data science and analytics, as well as therapeutics, genomics and other life science platforms. It backs companies across business-to-business and business-to-consumer models, software as a service, healthcare information technology and health tech sectors, partnering with repeat entrepreneurs to build durable, scale-ready businesses.

Innova Memphis is a Tennessee-based venture capital firm established in 2007 by the Memphis Bioworks Foundation. It focuses on biosciences, technology, and agri-tech companies at pre-seed, seed, early-stage, and high-growth stages across the United States. The firm provides funding and hands-on support to help early ideas evolve into viable business units and aims to connect portfolio companies with established corporations for licensing, acquisitions, or follow-on investments. By combining technical know-how, market expertise, and venture capital, Innova Memphis seeks to accelerate product development and help startups reach milestones and scale toward market leadership.

Aperture Venture Partners is a New York-based venture capital firm focused on healthcare, including medical devices, biopharmaceuticals, healthcare IT/services, and diagnostics. Founded in 2002, it seeks to back exceptional entrepreneurs addressing significant healthcare challenges and creating major opportunities. The firm invests nationally, with initial investments typically ranging from $1 million to $5 million. The principals bring decades of leadership in healthcare and investment and have a track record of substantial activity, having invested over $1 billion and supported companies that have achieved combined revenues exceeding $1 billion.

Broadview Ventures is the venture capital arm of the Leducq Foundation, focused on accelerating early-stage technology in cardiovascular and neurovascular disease. The firm targets seed, Series A and Series B rounds and invests in US and European startups developing therapeutics (small molecules and biologics), regenerative therapies (cell and gene therapies), medical devices (implantable, interventional, and monitoring), and stand-alone or companion diagnostics. It typically commits equity investments and provides strategic support to help translate research into clinical development. Founded in 2008 and based in Boston, Broadview Ventures partners with early-stage companies to bridge translational gaps and advance innovative life sciences technologies toward patient impact.

Founded in 2011, StartUp Health is dedicated to improving global health through collaboration with entrepreneurs. It invests in 'Health Transformers' across six continents, focusing on various health moonshots such as Access to Care, Cure Disease, and Mental Health. With over 330 companies in its portfolio, it's backed by prominent investors.

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across multiple stages, from seed to late-stage. It pursues transformative technologies and follows a founder-friendly investment approach that provides substantial support with minimal interference. The firm invests in ventures solving difficult problems across sectors such as aerospace and transportation, artificial intelligence, advanced computing, energy, healthcare, biotechnology, cybersecurity, fintech, consumer internet, software, robotics, and related technology fields. It has backed notable companies early, including SpaceX, Palantir, and Facebook, reflecting a history of partnering with ambitious founders to scale breakthrough technologies.